Russell Scammell is currently a Senior Director within small molecule drug discovery at Charles River. He has worked in the pharmaceutical industry for over 35 years at all stages of research and development where he has led the Pharmaceutics, Formulation, Chemistry and Analytical sciences groups at Aventis, Argenta Discovery and Charles River. Russell joined Charles River in 2014 and his primary role has been providing industry leading delivery of small molecule drug discovery pharmaceutical sciences and preclinical development expertise.